FALZETTI, Franca
 Distribuzione geografica
Continente #
NA - Nord America 3.065
EU - Europa 2.510
AS - Asia 1.901
SA - Sud America 336
AF - Africa 29
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.846
Nazione #
US - Stati Uniti d'America 3.002
SG - Singapore 836
IT - Italia 582
IE - Irlanda 444
CN - Cina 360
BR - Brasile 290
HK - Hong Kong 282
DE - Germania 246
UA - Ucraina 242
SE - Svezia 229
RU - Federazione Russa 222
FI - Finlandia 193
VN - Vietnam 180
KR - Corea 93
GB - Regno Unito 90
FR - Francia 65
RO - Romania 43
IN - India 33
TR - Turchia 32
MX - Messico 31
BE - Belgio 30
CZ - Repubblica Ceca 24
CA - Canada 23
AT - Austria 21
PL - Polonia 21
AR - Argentina 19
NL - Olanda 17
BD - Bangladesh 15
JP - Giappone 14
UZ - Uzbekistan 13
ZA - Sudafrica 11
CH - Svizzera 10
ES - Italia 9
LT - Lituania 9
EC - Ecuador 8
IQ - Iraq 7
GR - Grecia 5
LB - Libano 5
CL - Cile 4
CO - Colombia 4
ID - Indonesia 4
PK - Pakistan 4
PY - Paraguay 4
MA - Marocco 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
CI - Costa d'Avorio 1
CM - Camerun 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
RE - Reunion 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
YT - Mayotte 1
ZM - Zambia 1
Totale 7.846
Città #
Singapore 563
Chandler 499
Dublin 444
San Mateo 299
Hong Kong 282
Perugia 268
Ashburn 175
Boardman 157
Jacksonville 137
Ann Arbor 111
Santa Clara 110
Munich 101
Beijing 100
Seoul 93
Dong Ket 86
Medford 85
Princeton 83
Altamura 78
Andover 69
Moscow 66
Turku 62
Helsinki 60
Lawrence 58
Los Angeles 58
New York 57
Wilmington 56
Bucharest 40
Ho Chi Minh City 37
Brussels 30
Houston 30
Piscataway 28
Foligno 27
Dallas 25
Saint Petersburg 24
Dearborn 22
Izmir 22
Des Moines 21
Redwood City 21
São Paulo 21
Norwalk 20
Brooklyn 19
The Dalles 19
Brno 16
Hanoi 16
Mexico City 14
Shanghai 14
Tokyo 14
Warsaw 14
Bologna 13
Council Bluffs 13
Denver 13
London 13
San Francisco 13
San Paolo di Civitate 13
Rio de Janeiro 12
Stockholm 11
Assisi 10
Atlanta 10
Falkenstein 10
Falls Church 10
Frankfurt am Main 10
Nuremberg 10
Redmond 10
Vienna 10
West Jordan 10
Woodbridge 10
Orem 9
Auburn Hills 8
Boston 8
Groningen 8
Johannesburg 8
Rome 8
Belo Horizonte 7
Chicago 7
Florence 7
Guangzhou 7
Hefei 7
Milan 7
Olomouc 7
Poplar 7
Chennai 6
Curitiba 6
Montreal 6
Ottawa 6
Padova 6
San Jose 6
Amsterdam 5
Da Nang 5
Espoo 5
Phoenix 5
Quito 5
Sorocaba 5
Ankara 4
Bastia 4
Brasília 4
Changsha 4
Charlotte 4
Haiphong 4
Marsciano 4
Salvador 4
Totale 5.055
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 161
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 158
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 150
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 149
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 135
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 130
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 125
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 115
In Vivo Real Time Monitoring of Stem Cells Homing in Postischemic Tissues 115
Graft engineering for allogeneic haploidentical stem cell transplantation 114
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 113
Mesenchymal cells: a vehicle for gene therapy 112
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 112
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 107
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 106
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 106
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 105
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 105
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 105
IN VIVO DIRECT MONITORING OF STEM CELLS HOMING IN POSTISCHEMIC TISSUES 103
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 103
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 102
"Designed" grafts for HLA-haploidentical stem cell transplantation. 101
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 100
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 100
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 99
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 98
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 98
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 97
T regulatory cell separation for clinical application. 95
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 94
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 94
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 92
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 91
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 91
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 91
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 91
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 90
. Mismatched hematopoietic stem cell transplants in elderly patients. 89
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 88
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 88
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 87
Effetto della severità dell'ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicroscopia 86
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 85
Mismatched hematopoietic stem cell transplantation in secondary leukemia 83
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 83
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis 83
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 83
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 82
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 82
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 82
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 81
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 81
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 81
Stem cell mobilization in normal donors. 80
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 80
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era 79
Effetto della severità dell’ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicrosopia. 79
Reclutamento delle cellule staminali nei tessuti postischemici: valutazione diretta in vivo mediante videomicroscopia 76
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 75
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 75
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 75
New mechanism of lymphoma-induced bone marrow aplasia 75
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 74
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 74
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 72
Full haplotype mismatched transplant in high risk acute leukemia patients. 72
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 72
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 72
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 70
Mesenchymal cells recruit and regulate T regulatory cells. 70
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 68
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 68
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 68
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 66
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 65
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 64
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 64
Trapianto di cellule staminali nei tessuti post-ischemici: studio in vivo degli effetti delle cellule staminali sulla funzione microvascolare. 63
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 61
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 60
MOLECULAR AND BIOLOGICAL BASIS OF THE ASOCIATION OF RADIOTHERAPY, 5-FLUOROURACIL AND GEFITINIB IN RECTAL CANCER 60
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 60
Next generation HLA-haploidentical HSCT 59
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 59
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 59
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 56
Radioimmunotherapy with 90Y-ibritumomab tiuxetan to treat follicular non Hodgkin-lymphoma in relapse after autologous transplant or refractory to chemotherapy: preliminary results. 53
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 53
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 53
NOTCH and Graft-Versus-Host Disease 52
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 45
Uno strano caso di “eritema pernio” delle mani 45
null 37
Totale 8.105
Categoria #
all - tutte 36.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021384 0 0 0 0 0 58 51 12 78 26 59 100
2021/2022974 18 252 18 43 22 10 14 223 12 77 138 147
2022/20231.471 89 275 15 129 119 150 0 61 558 6 49 20
2023/2024746 30 69 37 29 3 20 178 9 46 38 128 159
2024/20251.523 60 141 60 76 198 52 91 98 260 85 255 147
2025/20261.662 220 201 166 411 464 200 0 0 0 0 0 0
Totale 8.105